Shunying Zhu

800 Dongchuan Road
Shanghai, 200240, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Tumour inhibitory activity on pancreatic cancer by bispecific nanobody targeting PD-L1 and CXCR4.

Tumour inhibitory activity on pancreatic cancer by bispecific nanobody targeting PD-L1 and CXCR4.

Journal: BMC cancer

Published: April 26, 2022

Antagonist effect of Interleukin 1 receptor on normal thymopoiesis and thymus toxicity of 5-azacytidine in mouse.

Antagonist effect of Interleukin 1 receptor on normal thymopoiesis and thymus toxicity of 5-azacytidine in mouse.

Journal: American journal of translational research

Published: December 11, 2015

CXCL4 mediates tumor regrowth after chemotherapy by suppression of antitumor immunity.

CXCL4 mediates tumor regrowth after chemotherapy by suppression of antitumor immunity.

Journal: Cancer biology & therapy

Published: October 20, 2015

Generation and Characterization of a New Monoclonal Antibody Against CXCL4.

Generation and Characterization of a New Monoclonal Antibody Against CXCL4.

Journal: Monoclonal antibodies in immunodiagnosis and immunotherapy

Published: April 22, 2015

Recombinant interleukin-1 receptor antagonist attenuates the severity of chronic pancreatitis induced by TNBS in rats.

Recombinant interleukin-1 receptor antagonist attenuates the severity of chronic pancreatitis induced by TNBS in rats.

Journal: Biochemical pharmacology

Published: November 05, 2014

The therapeutic effect of rhMK on osteoarthritis in mice, induced by destabilization of the medial meniscus.

The therapeutic effect of rhMK on osteoarthritis in mice, induced by destabilization of the medial meniscus.

Journal: Biological & pharmaceutical bulletin

Published: November 05, 2014

Exogenous IL-1Ra attenuates intestinal mucositis induced by oxaliplatin and 5-fluorouracil through suppression of p53-dependent apoptosis.

Exogenous IL-1Ra attenuates intestinal mucositis induced by oxaliplatin and 5-fluorouracil through suppression of p53-dependent apoptosis.

Journal: Anti-cancer drugs

Published: July 08, 2014

Activation of p38-MAPK by CXCL4/CXCR3 axis contributes to p53-dependent intestinal apoptosis initiated by 5-fluorouracil.

Activation of p38-MAPK by CXCL4/CXCR3 axis contributes to p53-dependent intestinal apoptosis initiated by 5-fluorouracil.

Journal: Cancer biology & therapy

Published: May 08, 2014

Functional receptors and intracellular signal pathways of midkine (MK) and pleiotrophin (PTN).

Functional receptors and intracellular signal pathways of midkine (MK) and pleiotrophin (PTN).

Journal: Biological & pharmaceutical bulletin

Published: April 04, 2014

The chemokine CXCL9 exacerbates chemotherapy-induced acute intestinal damage through inhibition of mucosal restitution.

The chemokine CXCL9 exacerbates chemotherapy-induced acute intestinal damage through inhibition of mucosal restitution.

Journal: Journal of cancer research and clinical oncology

Published: March 11, 2014

IL-1Ra selectively protects intestinal crypt epithelial cells, but not tumor cells, from chemotoxicity via p53-mediated upregulation of p21(WAF1) and p27(KIP1.).

IL-1Ra selectively protects intestinal crypt epithelial cells, but not tumor cells, from chemotoxicity via p53-mediated upregulation of p21(WAF1) and p27(KIP1.).

Journal: Pharmacological research

Published: January 20, 2014

Recombinant human interleukin-1 receptor antagonist reduces acute lethal toxicity and protects hematopoiesis from chemotoxicity in vivo.

Recombinant human interleukin-1 receptor antagonist reduces acute lethal toxicity and protects hematopoiesis from chemotoxicity in vivo.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: October 17, 2012

Showing 1-12 of 17

Last Updated: 09/26/2026